TCD's business model is to identify, evaluate and in-license breakthrough cutting-edge technologies, with a clear commercial rationale, after proof-of-concept and rapidly advance them through the completion of Phase II of the Regulatory process. The Company will than seek strategic alliances to assist it in reaching the market.

The Company's model offers opportunities for in-licensing by TCD of new discoveries as well as for out-licensing by TCD of its developed products to potential partners.

All rights reserved. 2011 TCD Pharma                                         Legal Statement                                                          Designed by Freeman y la luz